Earlier today, new stats were published by Cancer Research UK highlighting that two young adult Britons are diagnosed with skin cancer every day; a rate which has tripled since the 1970s. There were several factors highlighted as contributing to this increase, but one was most clearly singled out in the release:
“using a sunbed before the age of 35 can increase your risk of melanoma by 75%”
Since our announcement last year that Clinuvel would commence a new program for SCENESSE® (afamelanotide) in nonsegmental vitiligo, the company has received vast interest in the application of the drug in this disease. Of the enquiries that best captured the essence of this program, one stood out: a US based analyst asked how the company intended to objectively measure the response to treatment, the repigmentation of vitiliginous lesions, in its trial. (more…)
As part of our ongoing guest blogger series, we’ve invited Lee Thomas to share his experiences on the Clinuvel blog. Lee is an award winning US journalist who has spoken widely about his experiences with vitiligo, including in a documentary entitled ‘Turning White’. You can learn more about Lee at http://www.leethomas.com/
–
“What the…?” “Why me…?”
“Where is that trucking school info…?”
“My career is…”
I couldn’t even finish most sentences. (more…)
This is the second in a two-part blog series on devices used to detect skin cancers in humans. The first post, which you can read here, looks at existing tools.
In recent years, several scientific research organisations and companies have begun studying and refining devices designed to detect cancerous lesions on the skin.
Although it is unlikely that these innovative technologies will be a replacement for a dermatologist’s professional judgment, they may significantly aid and hasten the diagnosis process. Four of the latest technologies have caught the media’s attention in recent years. (more…)
As part of our ongoing focus on erythropoietic protoporphyria (EPP), we’ve invited Victoria to share her experiences with EPP as a guest blogger. You can read Victoria’s first post here.
When I was first diagnosed with EPP there was a huge sense of relief: someone had actually listened to me and believed that something wasn’t quite right.
That said, I am not overjoyed at having the condition as it restricts my life so much. When Spring starts to approach I get anxious as I dread having a reaction; my freedom to go out feels more restricted. (more…)
As part of our ongoing focus on erythropoietic protoporphyria (EPP), we’ve invited Victoria to share her experiences with EPP on the blog.
–
My name is Victoria; I am 26 years old and live in England. I was diagnosed with EPP at the age of 24. I fought for many years to get people to listen to me and understand EPP. I want to help raise awareness for this condition and also encourage those who suffer in silence to fight to get someone to listen to them. This is part of my story. (more…)
A recent study indicates that children whose mothers have worm infections during pregnancy may be at a lower risk of developing eczema.
The investigation took place in Uganda, a developing country where worm (helminth) infestations are common. The various types of worms can be contracted by several means: consuming food or water contaminated with worms or worm eggs; being bitten by a mosquito carrying worm larvae or through soil containing worms which penetrate the soles of the feet. (more…)
Today’s announcement of the results of CUV017 has brought with it a stream of updates from Clinuvel, on the website, YouTube and beyond.
In this post we summarise the days releases and developments.
With the northern Hemisphere officially creeping into summer, the first arguments of this season’s sun and skin debate have arisen
Anti cancer councils and organisations akin to Australia’s Sunsmart are continuing their awareness-raising campaigns, educating the public about the issue, and most importantly the practice of sun protective behaviour; although significant investment and persistence are required, well executed and long running campaigns can make significant progress, albeit on a regional scale. But a vocal group of skeptics are continuing to question whether a central element, sunscreen, might just be part of the problem.
June is global Acne Awareness Month, an initiative of the American Acne and Rosacea Society (AARS) to educate dermatologists involved with the care of patients with acne vulgaris (commonly referred to as acne).
According to the American Academy of Dermatology (AAD) over 80% of the American population have experienced acne, and in the USA alone, this skin disorder affects 60 million people at some stage in their life.
CEO blog (31)Clinuvel News (36)Erythropoietic Protoporphyria (22)Guest Bloggers (18)Issues & Discourse (122)Light & Health (110)Mothers & Children (6)Pharma Development (31)Scenesse (25)Vitiligo (19) |
© Clinuvel Pharmaceuticals Ltd 2009 |
